Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Former ACA Marketplace enrollee: ‘This is ridiculous—$1,200 and an $8,000 deductible for a healthy person. Really?’
A new KFF survey shows almost 10% of people who had an Obamacare Marketplace plan in 2025 decided to head into 2026 with no coverage at all. Another 28% re-enrolled but with a different—presumably lesser—plan.
Healthcare price transparency startup earns $40M in seed funding, bringing the total to $95M
San Diego-based Turquoise Health was founded in 2020 and has evolved to be a healthcare pricing engine used to develop health plan networks and contract rates. The company said its end goal is complete price transparency to make it easier for all organizations and patients to navigate the U.S. healthcare system.
EP advocacy group details 6 key policy issues
The Heart Rhythm Society's advocacy arm is monitoring such issues as prior authorization, outpatient payment policies and cancelled research funding.
Consolidation, competition, consumer costs: Healthcare econ experts break it all down, make it make sense
Market forces like competition cannot stem the urge to merge among and between payers and providers, so neither will they staunch the price hikes in premiums.
MGMA outlines path and pitfalls in CMS 2030 value-based care push
The Center for Medicare and Medicaid Innovation (CMMI) has tested nearly 40 APMs, of which only two turned out to be successful, which does not bode well for meeting a 2030 deadline to transition to value-based payments.

About 40% of rads said they accept studies across all areas of expertise. Yet, less than half are “very confident” reading them.

The publicly traded, Deerfield, Illinois-based vendor plans to pursue an auction of its assets through court proceedings, leaders announced Tuesday.

The Drug Price Negotiation Program already has changed how the company considers the development of future oncology programs and medications.

Eileen Appelbaum, PhD, spoke during the Take Back Medicine summit, focused on the theme of “reclaiming medicine from corporate interests.”

The Los Angeles-based imaging center operator sold a total of 8,711,250 shares of its stock at $29.75 apiece.

The 22,632 square-foot center will include four wide-bore MRIs and upgraded PET and CT scanners, leaders announced recently.

Co-founded by radiologist Osmanuddin Ahmed, MD, Flow Medical is creating a first-of-its-kind product for treating pulmonary embolism.

The Metairie, Louisiana-based radiology group has doubled in size since Clearview Capital funded the company in October 2020.